Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Atco, NJ
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Atco, NJ
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
New York, NY
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Charlotte, NC
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Mooresville, NC
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Mooresville, NC
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Morganton, NC
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Morganton, NC
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Cincinnati, OH
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Columbus, OH
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Dayton, OH
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Willoughby, OH
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Willoughby, OH
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Rapid City, SD
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Memphis, TN
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Austin, TX
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
El Paso, TX
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Houston, TX
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Bountiful, UT
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Bountiful, UT
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Phoenix, AZ
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Birmingham, AL
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Doral, FL
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Doral, FL
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Hialeah, FL
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Port Orange, FL
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Port Orange, FL
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Towson, MD
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Towson, MD
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Gresham, OR
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Gresham, OR
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Jackson, TN
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Smyrna, TN
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Smyrna, TN
Click here to add this to my saved trials
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated:  3/2/2017
Clinical Research Facility
mi
from
Boerne, TX
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Status: Enrolling
Updated: 3/2/2017
Clinical Research Facility
mi
from
Boerne, TX
Click here to add this to my saved trials
IR and Microvascular Blood Flow in SCI
Insulin Resistance and Microvascular Blood Flow in Spinal Cord Injury
Status: Enrolling
Updated:  3/6/2017
James J Peters VA Medical Center
mi
from
Bronx, NY
IR and Microvascular Blood Flow in SCI
Insulin Resistance and Microvascular Blood Flow in Spinal Cord Injury
Status: Enrolling
Updated: 3/6/2017
James J Peters VA Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Vitamin D Deficiency and Replacement on Pulmonary and Endocrine Function in SCI
Effects of Vitamin D Deficiency and Its Replacement on Pulmonary and Endocrine Function in Persons With SCI
Status: Enrolling
Updated:  3/6/2017
James J Peters VA Medical Center
mi
from
Bronx, NY
Vitamin D Deficiency and Replacement on Pulmonary and Endocrine Function in SCI
Effects of Vitamin D Deficiency and Its Replacement on Pulmonary and Endocrine Function in Persons With SCI
Status: Enrolling
Updated: 3/6/2017
James J Peters VA Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI
A Novel Application of Iontophoresis in the Transcutaneous Delivery of a Prokinetic Agent for the Promotion of Bowel Evacuation
Status: Enrolling
Updated:  3/6/2017
James J Peters VA Medical Center
mi
from
Bronx, NY
Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI
A Novel Application of Iontophoresis in the Transcutaneous Delivery of a Prokinetic Agent for the Promotion of Bowel Evacuation
Status: Enrolling
Updated: 3/6/2017
James J Peters VA Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/7/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/7/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/7/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/7/2017
mi
from
Lille,
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta
A Multicenter Postmarketing Study to Evaluate the Placental Transfer of Certolizumab Pegol in Pregnant Women Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/7/2017
mi
from
Lille,
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Annapolis, MD
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Annapolis, MD
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Sartell, MN
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Sartell, MN
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Southaven, MS
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Southaven, MS
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Bismarck, ND
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Bismarck, ND
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Laguna Hills, CA
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
San Diego, CA
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Tarzana, CA
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Tarzana, CA
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Torrance, CA
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Denver, CO
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Englewood, CO
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Englewood, CO
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Aventura, FL
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Ocala, FL
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Orlando, FL
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Sarasota, FL
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Meridian, ID
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Baltimore, MD
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Glen Burnie, MD
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated:  3/9/2017
Clinical Research Facility
mi
from
Towson, MD
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018
Status: Enrolling
Updated: 3/9/2017
Clinical Research Facility
mi
from
Towson, MD
Click here to add this to my saved trials